Perspectives
  • Perspectives
  • Journals
  • Proceedings
  • Conferences
No Result
View All Result
PERSPECTIVES
Perspectives
  • Perspectives
  • Journals
  • Proceedings
  • Conferences
No Result
View All Result
Perspectives
No Result
View All Result

Green Tea Polyphenols, Epigallocatechin Gallate and Epicatechin Synergistically Altering Production of Th1 and T Regulatory Cytokines by Normal and Leukemic T Lymphocytes

Lisa A. Beltz

Malone University, Canton, Ohio, USA

DOI: https://doi.org/10.5897/PP2018/0004

Copyright © 2018 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.

 

Green tea is one of the most popular drinks in the world, second only to water. It acts as an anti-oxidant and is beneficial in the treatment of cancer, obesity, viral infections (including HIV), and Alzheimer’s disease. Unlike drugs or many plant-derived medicinal compounds, green tea is readily available, inexpensive, and has a pleasant taste. These qualities make it an excellent addition to therapies for many diseases, either alone or combined with some other drugs. Polyphenols are powerful anti-oxidants found in green tea.  Epigallocatechin gallate (EGCG) is the most abundant, active, and best studied green tea polyphenols and is often used in its purified form to treat illnesses. Epicatechin (EC) is found in lower concentrations in green tea and appears to have less medicinal value alone. This study briefly shows that EGCG combined with EC works much better than either polyphenol alone in stimulating normal human T lymphocyte functions and reducing growth of cancerous T lymphocytes.

Normal T lymphocytes, especially Th1 cells, are the cornerstone of the immune response, especially in defense against viruses. They are stimulated to divide and increase their activities by the Th1 cytokine (immune messenger molecule) tumor necrosis factor-beta (TNF-beta) and their division and activity  are decreased by the T regulatory cytokine interleukin-10 (IL-10). High levels of TNF-beta and low levels of IL-10 thus stimulate normal T lymphocytes to grow and protect the body from multiple diseases. Growth of cancerous T lymphocytes is similar, so that effective treatment for this leukemia would lower levels of TNF-beta, increase levels of IL-10, and block leukemic cell growth.

Table 1 shows that growth of leukemic T lymphocytes is decreased by EC as its concentration is increased from 0 μM EC (78,339) to 100 μM EC (52,888). EGCG alone also reduces leukemia growth as its concentration is raised from 0 μM EGCG (78,339) to 20 μM EGCG (4679). Using both 100 μM EC and 20 μM EGCG lowers leukemic cell growth even more (2848) for a decrease in growth of 96%. Normal T lymphocyte growth (Table 2) in the absence of EC and EGCG is 22,045 and also decreases in the presence of 100 μM EC and 20 μM EGCG down to 14,624, a decrease of only 34%. Combining EC and EGCG, therefore, decreases growth of protective, normal T lymphocytes much less than that of leukemia cells.

Table 1. Growth of Leukemic Lymphocytes

EGCG 0 EGCG 10 EGCG 20
EC 0 78339 34586 4679
EC 50 52399 26654 4648
EC100 52888 19810 2848

Table 2. Growth of Normal Lymphocytes

EGCG 0 EGCG 10 EGCG 20
EC 0 22045 20168 20437
EC 50 15531 16624 16666
EC100 16753 17328 14264

Production of Th1 cytokine and growth factor TNF-beta by leukemia cells (Table 3) is not affected by a combination of 100 μM EC and 20 μM EGCG (46 pM TNF in the absence of EC and EGCG compared to 44 pM in the presence of both polyphenols). Production of TNF-beta by normal T lymphocytes (Table 4), however, increases from 344 pM TNF in the absence of EC and EGCG up to 2779 pM TNF, an 8-fold increase. These data show that combining EC and EGCG increases production of the protective growth factor TNF-beta by normal, but not leukemic, lymphocytes.

Production of the T regulatory and anti-growth cytokine IL-10 by leukemia cells (Table 5) is greatly increased by a combination of 100 μM EC and 20 μM EGCG (210 pM IL-10 in the absence of EC and EGCG compared to 1971 pM in the presence of both polyphenols; 9-fold increase). Production of IL-10 by normal T lymphocytes (Table 6), however, is much less affected by EC and 

Table 3. TNF-beta Production by Leukemic Lymphocytes

EGCG 0 EGCG 10 EGCG 20
EC 0 46 41 33
EC 50 46 46 43
EC100 51 46 44

Table 4. TNF-beta Production by Normal Lymphocytes

EGCG 0 EGCG 10 EGCG 20
EC 0 344 385 736
EC 50 504 756 1677
EC100 937 2186 2770

 

Table 5. IL-10 Production by Leukemic Lymphocytes

EGCG 0 EGCG 10 EGCG 20
EC 0 210 341 729
EC 50 569 811 975
EC100 610 1035 1971

 

Table 6. IL-10 Production by Normal Lymphocytes

EGCG 0 EGCG 10 EGCG 20
EC 0 651 613 710
EC 50 739 608 755
EC100 838 750 902

EGCG (651 pM IL-10 in the absence of EC and EGCG compared to 902 pM IL-10, an increase of only 28%. These data show that combining EC and EGCG increases production of the anti-growth cytokine IL-10 much more powerfully by leukemic lymphocytes than normal ones.

This study shows that a combination of green tea polyphenols, EC and EGCG is much more effective than either polyphenol alone in stopping growth of leukemic T cells and production of associated cytokines and encouraging growth of protective normal T lymphocytes.

About the author

Lisa A. Beltz
Professor (Associate) at School of Theology, Arts, and Sciences, Malone University

Lisa Beltz Education. B.A., Malone University; Ph.D., Michigan State ... Human Anatomy & Physiology; Virology; Principles of Immunology; General Biology and expertise in Parasitology, Cancer Research, Immunology.

    This author does not have any more posts.
Tags: HEALTH AND MEDICAL SCIENCIES
Previous Post

Telling DNA what to do and how to do it: A Perspective article summarizing “Cell Cycle-Specific Cleavage of Scc2 Regulating its Cohesin Deposition Activity” and “Phosphorylation of the Scc2 cohesin deposition complex subunit regulating chromosome condensation through cohesin integrity”

Next Post

Polyunsaturated Fatty Acids Therapies, with Special Emphasis on Coronary Heart Disease

Next Post
Polyunsaturated Fatty Acids Therapies, with Special Emphasis on Coronary Heart Disease

Polyunsaturated Fatty Acids Therapies, with Special Emphasis on Coronary Heart Disease

Perspective on the regulations of Drosophila Phototransduction

About Perspectives

PERSPECTIVES aims at bringing the exciting world of science to a larger audience who may not have the requisite knowledge to understand complex and technical research findings as those published in conventional journal articles.

Perspectives articles are very simplified and summarized version of scientific researches. These articles tell a simple story about the research, the findings and their applications in such a manner that the article is understood by people who do not have the requisite background knowledge on the subject.

Email: perspectives@academicjournals.org

Archives

Authors

Categories

HEALTH AND MEDICAL SCIENCES (2) HEALTH AND MEDICAL SCIENCIES (6) LIFE SCIENCES (2) NATURAL SCIENCE (1)

AUTHORS

  • Submit Manuscript
  • Track Manuscript
  • Publication Ethics
  • Editorial Policies
  • Publication Fee
  • Waiver Policy
  • Print Request
  • FAQ

REVIEWERS

  • Reviewers Guidelines
  • Peer Review

POLICIES

  • Open Access
  • Creative Commons
  • CrossMark Policy
  • Digital Archiving
  • Self-Archiving
  • Article Copyright

READERS

  • Journals
  • Proceedings
  • News
  • Articles
  • Search Articles
  • Conference Announcements
  • Subscribe to RSS

EDITORS

  • Editors

ABOUT

  • About Us
  • Memberships & Standards
  • Open Archives Initiatives
  • Support Center
  • Subscribe to RSS
  • Terms of use
  • Contact

© Academic Journals 2002 - 2019

No Result
View All Result

© Academic Journals 2002 - 2019